首页> 外文OA文献 >>Increased systemic immune-inflammation index independently predicts poor survival for hormone receptor-negative, HER2-positive breast cancer patients

【2h】

>Increased systemic immune-inflammation index independently predicts poor survival for hormone receptor-negative, HER2-positive breast cancer patients

机译：>增加全身免疫炎症指数，独立预测激素受体阴性，HER2阳性乳腺癌患者的不良存活率

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Yi Sun; Wenqiang Li; Ai-Jie Li; Huichao Su; Jinbo Yue; Jinming Yu;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Increased systemic immune-inflammation index independently predicts poor survival for hormone receptor-negative, HER2-positive breast cancer patients [J] . Yi Sun, Wenqiang Li, Ai-Jie Li, Cancer Management and Research . 2019,第2期

机译：全身免疫炎症指数的增加独立预测荷尔蒙受体阴性，HER2阳性乳腺癌患者的不良生存
2. High Systemic Immune-Inflammation Index Predicts Poor Survival in Patients with Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Receiving Adjuvant Trastuzumab [J] . Li Jiang, Jianjiang Fang, Jinhua Ding Cancer Management and Research . 2020,第4期

机译：高全身免疫炎症指数预测人表皮生长因子受体-2阳性乳腺癌接受佐剂曲据的患者存活率不佳
3. Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection [J] . Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract . 2020,第3期

机译：全身免疫炎症指数（SII）预测胰腺癌患者进行切除的差的存活率
4. Chemoprevention of Hormone Receptor-Negative Breast Cancer:New Approaches Needed [C] . I.P. Uray and P.H. Brown International Conference on Clinical Cancer Prevention . 2011

机译：激素受体阴性乳腺癌的化学预防：所需的新方法
5. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
6. Increased systemic immune-inflammation index independently predicts poor survival for hormone receptor-negative HER2-positive breast cancer patients [O] . Yi Sun, Wenqiang Li, Ai-Jie Li, 2019

机译：全身免疫炎症指数的升高独立预测荷尔蒙受体阴性HER2阳性乳腺癌患者的不良生存
7. >High Systemic Immune-Inflammation Index Predicts Poor Survival in Patients with Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Receiving Adjuvant Trastuzumab [O] . Li Jiang, Jianjiang Fang, Jinhua Ding 2020

机译：>高全身免疫炎症指数预测人体表皮生长因子受体-2阳性乳腺癌患者的存活率差，接受佐剂曲妥珠单抗

>Increased systemic immune-inflammation index independently predicts poor survival for hormone receptor-negative, HER2-positive breast cancer patients

著录项

引文网络

相似文献

相关主题

期刊订阅